QUICK ANSWER · AEO / GEO
SNAP-8 is associated with the cosmetic ingredient acetyl octapeptide-3, not Argireline or botulinum toxin. Limited human studies concern multi-ingredient serum and hyaluronic-acid microneedle patches, not isolated SNAP-8. The serum study enrolled 33 women and analysed 31 completers without a concurrent human control; its authors were company employees. Formulation outcomes cannot establish peptide-only efficacy, Botox equivalence or injection safety. Cosmetic notification and INCI/CosIng information do not establish injectable drug approval; exact product status remains unverified.
ENTITY FACTS
What should readers identify first?
What remains unknown?
Insufficient data in the current dataset
What limits these conclusions?
Insufficient data in the current dataset
This overview does not replace the detailed adverse-event and product-specific risk discussion in the complete Thai profile or the original sources.
EVIDENCE BOUNDARY
What this overview does not establish
- An evidence grade does not rank this molecule against another treatment.
- A molecule name does not establish the identity, purity or regulatory status of a product.
- Animal, cell or biomarker findings do not automatically establish human clinical benefit.
- Approval in one country or indication does not transfer globally.
Where can I check the evidence?
Original sources from the same evidence record used by Compare. Read each source's population, methods, limitations and date; a citation is not product endorsement.
- https://pubmed.ncbi.nlm.nih.gov/35426243/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10084013/
- https://pubmed.ncbi.nlm.nih.gov/31134751/
- https://pubmed.ncbi.nlm.nih.gov/18498523/
- https://www.lubrizol.com/solutions/products/beauty/detail-pages/snap-8-peptide-solution-c
- https://www.fda.moph.go.th/news/%E0%B8%A2%E0%B8%B2%E0%B8%89%E0%B8%B5%E0%B8%94
- https://www.fda.gov/cosmetics/cosmetic-products/wrinkle-treatments-and-other-anti-aging-products
- https://www.fda.gov/medical-devices/aesthetic-cosmetic-devices/microneedling-devices
- https://single-market-economy.ec.europa.eu/sectors/cosmetics/cosmetic-ingredient-database_en
FAQ · ANSWER ENGINE
Frequently asked questions
What is SNAP-8 (Acetyl Octapeptide-3)?
SNAP-8 (Acetyl Octapeptide-3) is described pharmacologically as Synthetic cosmetic octapeptide; proposed SNARE-related activity, not botulinum toxin. SNAP-8 is associated with the cosmetic ingredient acetyl octapeptide-3, not Argireline or botulinum toxin. Limited human studies concern multi-ingredient serum and hyaluronic-acid microneedle patches, not isolated SNAP-8. The serum study enrolled 33 women and analysed 31 completers without a concurrent human control; its authors were company employees. Formulation outcomes cannot establish peptide-only efficacy, Botox equivalence or injection safety. Cosmetic notification and INCI/CosIng information do not establish injectable drug approval; exact product status remains unverified.
Does SNAP-8 (Acetyl Octapeptide-3) have strong evidence?
PrimeCoreBio records Evidence Grade D. This grade describes evidence strength, not comparative effectiveness or suitability for an individual.
Is SNAP-8 (Acetyl Octapeptide-3) approved everywhere?
No global conclusion should be inferred. PrimeCore Class C must be read with the exact product, country and indication on the source-rich profile.
Educational information only. This page does not provide diagnosis, treatment, prescribing, dosage, injection instructions or individual medical advice.